This use is most relevant for: People with regular alcohol consumption Those with high urban pollution or significant occupational toxin exposure Anyone dealing with an elevated environmental heavy metal load 3
observed PBM-reality
Gastrointestinal tolerability and weight reduction associated with tirzepatide in adults with obesity or overweight with and without type 2 diabetes in the SURMOUNT-1 to -4 trials
In December 2023, the company discontinued the twice-daily immediate-release formulation for obesity due to tolerability issues, primarily gastrointestinal side effects
It is also appropriate for many patients to transition to a less expensive oral medication (such as Tenuate / diethylpropion, phentermine, Qsymia or Contrave) vs
L., Fu, A., Zhao, P., Li, J., Geng, L., Smith, S